Liposomes represent potential new method for delivering agents to the brain

A new nanontechnology developed by researchers at Penn State College of Medicine (PA,USA) may enable doctors to detect gliomas earlier than previously possible. With a median survival rate of 14 months following diagnosis, the technology could provide an opportunity to make the currently fatal cancer treatable. The study was published recently in the Journal of Neuro-Oncology. Despite patients rarely dying due to their initial tumor, new gliomas often grow quickly and become resistant to treatment. Follow-up MRIs are given to glioma patients, however the tests rarely identify the tumors early enough to save the patient’s lives. This is due to...